secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001213900-23-058659
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics announces 1-for-20 reverse stock split to meet Nasdaq minimum bid price, effective July 24, 2023
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-20; authorized shares reduced from 100M to 7.5M; outstanding shares from ~20.5M to ~1.02M.
- Effective 12:01 a.m. ET July 24, 2023; shares trade post-split on Nasdaq under same symbol BJDX with new CUSIP 095633301.
- Split ensures compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing.
- No fractional shares issued; cash payment in lieu based on ten-day average closing price.
- Outstanding warrants and equity awards adjusted proportionally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023058659/0001213900-23-058659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023058659/ea182103-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-058659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer